Thyroid Hormone Replacement for Hypothyroidism and Acute Myocardial Infarction(ThyroHeart-AMI)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.
Also called NCT02512978
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 160 participants
- Sponsor
- Beijing Anzhen Hospital
- Beijing Chao Yang Hospital
- Beijing Friendship Hospital
- Beijing Municipal Science & Technology Commission
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Peking Union Medical College Hospital
- Peking University Third Hospital
- The Luhe Teaching Hospital of the Capital Medical University
- Registry
-
NCT02512978
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02512978. Randomized; no masking; primary purpose treatment. Start 2015-08 (actual); primary completion 2018-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Thyroid Hormone Replacement for Hypothyroidism and Acute Myocardial Infarction(ThyroHeart-AMI)
- Condition
- Myocardial Infarction
- Condition
- Hypothyroidism
- Intervention (Drug)
- Levothyroxine
- Lead sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Collaborator
- Beijing Municipal Science & Technology Commission
- Collaborator
- Peking Union Medical College Hospital
- Collaborator
- Peking University Third Hospital
- Collaborator
- Beijing Anzhen Hospital
- Collaborator
- Beijing Chao Yang Hospital
- Collaborator
- Beijing Friendship Hospital
- Collaborator
- The Luhe Teaching Hospital of the Capital Medical University
Record details
- Record id
cardio:ct-nct02512978- Content hash
ffe427f4a084353992a2cfc9b1b0789c6917d1cc6d49f13975e32981d10b7f27